U.S. Physical Therapy, Inc. to Post Q1 2025 Earnings of $0.55 Per Share, Barrington Research Forecasts (NYSE:USPH)

U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) - Analysts at Barrington Research upped their Q1 2025 EPS estimates for U.S. Physical Therapy in a research note issued on Thursday, May 9th. Barrington Research analyst M. Petusky now anticipates that the company will post earnings per share of $0.55 for the quarter, up from their prior forecast of $0.54. Barrington Research has a "Outperform" rating and a $122.00 price objective on the stock. The consensus estimate for U.S. Physical Therapy's current full-year earnings is $2.77 per share. Barrington Research also issued estimates for U.S. Physical Therapy's Q2 2025 earnings at $0.89 EPS, Q3 2025 earnings at $0.79 EPS, Q4 2025 earnings at $0.82 EPS and FY2026 earnings at $3.45 EPS.

Several other research firms have also recently weighed in on USPH. StockNews.com upgraded shares of U.S. Physical Therapy from a "sell" rating to a "hold" rating in a research note on Monday, March 18th. JPMorgan Chase & Co. lifted their target price on shares of U.S. Physical Therapy from $99.00 to $117.00 and gave the company an "overweight" rating in a research report on Wednesday, March 13th. One equities research analyst has rated the stock with a hold rating and four have given a buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $125.67.

U.S. Physical Therapy Stock Performance

Shares of NYSE:USPH traded up $1.44 during midday trading on Friday, hitting $106.48. The company's stock had a trading volume of 60,867 shares, compared to its average volume of 69,138. U.S. Physical Therapy has a fifty-two week low of $78.08 and a fifty-two week high of $124.11. The company has a debt-to-equity ratio of 0.29, a quick ratio of 2.28 and a current ratio of 2.28. The stock has a market capitalization of $1.60 billion, a price-to-earnings ratio of 77.84, a PEG ratio of 4.99 and a beta of 1.39. The stock's 50 day simple moving average is $105.32 and its 200 day simple moving average is $96.43.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last announced its earnings results on Tuesday, May 7th. The company reported $0.51 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.58 by ($0.07). U.S. Physical Therapy had a return on equity of 8.52% and a net margin of 4.67%. The company had revenue of $155.70 million for the quarter, compared to analyst estimates of $153.30 million. During the same period last year, the firm earned $0.59 earnings per share. The firm's revenue for the quarter was up 4.8% on a year-over-year basis.

U.S. Physical Therapy Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, June 14th. Stockholders of record on Thursday, May 23rd will be issued a dividend of $0.44 per share. This represents a $1.76 annualized dividend and a dividend yield of 1.65%. The ex-dividend date is Wednesday, May 22nd. U.S. Physical Therapy's payout ratio is 130.37%.

Insider Activity

In other news, CFO Carey P. Hendrickson sold 1,800 shares of the firm's stock in a transaction on Wednesday, March 13th. The stock was sold at an average price of $107.28, for a total value of $193,104.00. Following the completion of the sale, the chief financial officer now directly owns 21,186 shares in the company, valued at $2,272,834.08. The sale was disclosed in a filing with the SEC, which is accessible through this link. In related news, EVP Richard Binstein sold 2,000 shares of the stock in a transaction that occurred on Wednesday, March 13th. The shares were sold at an average price of $106.55, for a total value of $213,100.00. Following the transaction, the executive vice president now directly owns 15,006 shares in the company, valued at $1,598,889.30. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CFO Carey P. Hendrickson sold 1,800 shares of the stock in a transaction on Wednesday, March 13th. The shares were sold at an average price of $107.28, for a total value of $193,104.00. Following the completion of the transaction, the chief financial officer now directly owns 21,186 shares in the company, valued at approximately $2,272,834.08. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 10,829 shares of company stock worth $1,141,535. Insiders own 1.70% of the company's stock.

Institutional Investors Weigh In On U.S. Physical Therapy

Large investors have recently bought and sold shares of the company. RK Capital Management LLC acquired a new position in U.S. Physical Therapy during the 4th quarter worth approximately $6,166,000. Norden Group LLC boosted its stake in shares of U.S. Physical Therapy by 1,841.6% during the 1st quarter. Norden Group LLC now owns 63,938 shares of the company's stock worth $7,217,000 after buying an additional 60,645 shares during the last quarter. Envestnet Asset Management Inc. grew its holdings in shares of U.S. Physical Therapy by 53.2% in the 3rd quarter. Envestnet Asset Management Inc. now owns 163,956 shares of the company's stock valued at $15,040,000 after acquiring an additional 56,957 shares in the last quarter. Bahl & Gaynor Inc. raised its holdings in U.S. Physical Therapy by 95.5% during the fourth quarter. Bahl & Gaynor Inc. now owns 100,315 shares of the company's stock worth $9,343,000 after acquiring an additional 49,013 shares in the last quarter. Finally, Schroder Investment Management Group boosted its position in U.S. Physical Therapy by 11.0% during the fourth quarter. Schroder Investment Management Group now owns 427,217 shares of the company's stock valued at $39,791,000 after purchasing an additional 42,281 shares during the last quarter.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.